Related references
Note: Only part of the references are listed.Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study
C. M. Phelan et al.
BRITISH JOURNAL OF CANCER (2014)
Colorectal cancer statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Kelly-Anne Phillips et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials
Peter M. Rothwell et al.
LANCET (2012)
The natural history of colorectal adenomas and early cancer
M. Risio
PATHOLOGE (2012)
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
Peter M. Rothwell et al.
LANCET (2011)
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
John Burn et al.
LANCET (2011)
Preventive therapy for breast cancer: a consensus statement
Jack Cuzick et al.
LANCET ONCOLOGY (2011)
BRCA1 mutations and colorectal cancer in Poland
Janina Suchy et al.
FAMILIAL CANCER (2010)
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
Peter M. Rothwell et al.
LANCET (2010)
Vitamin D for Cancer Prevention: Global Perspective
Cedric F. Garland et al.
ANNALS OF EPIDEMIOLOGY (2009)
Aspirin for the Chemoprevention of Colorectal Adenomas: Meta-analysis of the Randomized Trials
Bernard F. Cole et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (Hemoccult): An update
Paul Hewitson et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
Bernard Levin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Cancer risks in carriers of the BRCA1/2 Ashkenazi founder mutations
Luna Kadouri et al.
JOURNAL OF MEDICAL GENETICS (2007)
Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: US preventive services task force recommendation statement
ANNALS OF INTERNAL MEDICINE (2007)
Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: A kin-cohort study in Ontario, Canada
Harvey A. Risch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Cohort studies: Marching forward
Ravi Thadhani et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Risk of developing colorectal cancer following a negative colonoscopy examination - Evidence for a 10-year interval between colonoscopies
Harminder Singh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Aspirin and cancer risk: an updated quantitative review to 2005
Cristina Bosetti et al.
CANCER CAUSES & CONTROL (2006)
Vitamin D and prevention of colorectal cancer
ED Gorham et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
Prevalence of family history of colorectal cancer in the general population
RJ Mitchell et al.
BRITISH JOURNAL OF SURGERY (2005)
Analysis of risk of bleeding complications after different doses of Aspirin in 192,036 patients enrolled in 31 randomized controlled trials
VL Serebruany et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Frequency of familial colon cancer and hereditary nonpolyposis colorectal cancer (Lynch syndrome) in a large population database
RA Kerber et al.
FAMILIAL CANCER (2005)
Frequency of BRCA1 and BRCA2 mutations in unselected Ashkenazi Jewish patients with colorectal cancer
T Kirchhoff et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer
BL Niell et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
A Antoniou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
A randomized trial of aspirin to prevent colorectal adenomas
JA Baron et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The effect of a single BRCA2 mutation on cancer in Iceland
H Tulinius et al.
JOURNAL OF MEDICAL GENETICS (2002)
Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer
HA Risch et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients
R Chen-Shtoyerman et al.
BRITISH JOURNAL OF CANCER (2001)
BRCA2 is required for homology-directed repair of chromosomal breaks
ME Moynahan et al.
MOLECULAR CELL (2001)
Share Paper
